Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Calcium signaling pathway | R-HSA-381753 | map04020 | flunisolide | 82153 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | flunisolide | 82153 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | flunisolide | 82153 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | flunisolide | 82153 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | flunisolide | 82153 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | flunisolide | 82153 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | flunisolide | 82153 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | flunisolide | 82153 | drug-path |
| Primary immunodeficiency | R-HSA-5601905 | map05340 | ipratropium bromide | 4581 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | ipratropium bromide | 4581 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | ipratropium bromide | 4581 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | ipratropium bromide | 4581 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ipratropium bromide | 4581 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ipratropium bromide | 4581 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | ipratropium bromide | 4581 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | ipratropium bromide | 4581 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | ipratropium bromide | 4581 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | atropine | 174174 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | atropine | 174174 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | atropine | 174174 | drug-path |